Search research articles
Contact Us
Filters
Showing results (11-20 of 368) with videos related to
Page
of 37
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 22, 2011
Recognizing and preventing death from compensated cirrhosis in the community
Jason Grebely, Jayant A Talwalkar
Hepatology (Baltimore, Md.)
|
December 6, 2011
An expanding role for primary care providers in the treatment of hepatitis C virus infection in the community
Jason Grebely, Gregory J Dore
Nature Reviews. Gastroenterology & Hepatology
|
December 2, 2010
Hepatitis C: Enhancing treatment for hepatitis C among drug users
Jason Grebely, Gregory J Dore
Current Opinion in HIV and AIDS
|
October 18, 2011
Management of HCV and HIV infections among people who inject drugs
Jason Grebely, Mark W Tyndall
Journal of Hepatology
|
April 16, 2017
Negotiating better discounts for DAA therapy is critical to achieve HCV elimination by 2030
Gregory J Dore, Jason Grebely
The International Journal on Drug Policy
|
November 13, 2020
COVID-19 and the health of people who use drugs: What is and what could be?
Jason Grebely, Magdalena Cerdá, Tim Rhodes
The Lancet. Gastroenterology & Hepatology
|
April 12, 2017
Direct-acting antivirals for acute HCV: how short can we go?
Marianne Martinello, Jason Grebely, Gail V Matthews
Journal of Hepatology
|
October 27, 2023
Reply to: " 'One-stop-shop' point-of-care hepatitis C RNA testing intervention in the prison - some issues"
Yumi Sheehan, Jason Grebely, Andrew R Lloyd
Journal of Hepatology
|
July 17, 2012
Case definitions for acute hepatitis C virus infection: a systematic review
Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 6, 2020
Creating an environment for equitable access to direct-acting antiviral therapy for people who inject drugs with hepatitis C
Gregory J Dore, Heather Valerio, Jason Grebely
Page
of 37
Search research articles
Search
Showing results (11-20 of 368) with videos related to
Sort By:
Page
of 37
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 22, 2011
Recognizing and preventing death from compensated cirrhosis in the community
Jason Grebely, Jayant A Talwalkar
Hepatology (Baltimore, Md.)
|
December 6, 2011
An expanding role for primary care providers in the treatment of hepatitis C virus infection in the community
Jason Grebely, Gregory J Dore
Nature Reviews. Gastroenterology & Hepatology
|
December 2, 2010
Hepatitis C: Enhancing treatment for hepatitis C among drug users
Jason Grebely, Gregory J Dore
Current Opinion in HIV and AIDS
|
October 18, 2011
Management of HCV and HIV infections among people who inject drugs
Jason Grebely, Mark W Tyndall
Journal of Hepatology
|
April 16, 2017
Negotiating better discounts for DAA therapy is critical to achieve HCV elimination by 2030
Gregory J Dore, Jason Grebely
The International Journal on Drug Policy
|
November 13, 2020
COVID-19 and the health of people who use drugs: What is and what could be?
Jason Grebely, Magdalena Cerdá, Tim Rhodes
The Lancet. Gastroenterology & Hepatology
|
April 12, 2017
Direct-acting antivirals for acute HCV: how short can we go?
Marianne Martinello, Jason Grebely, Gail V Matthews
Journal of Hepatology
|
October 27, 2023
Reply to: " 'One-stop-shop' point-of-care hepatitis C RNA testing intervention in the prison - some issues"
Yumi Sheehan, Jason Grebely, Andrew R Lloyd
Journal of Hepatology
|
July 17, 2012
Case definitions for acute hepatitis C virus infection: a systematic review
Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 6, 2020
Creating an environment for equitable access to direct-acting antiviral therapy for people who inject drugs with hepatitis C
Gregory J Dore, Heather Valerio, Jason Grebely
Page
of 37